Sorafenib Induced Hand Foot Skin Rash in FLT3 ITD Mutated Acute Myeloid Leukemia-A Case Report and Review of Literature

Sorafenib is a novel small molecule multiple kinase inhibitor which has been used for metastatic renal cancer, hepatocellular cancer. Sorafenib induced skin rash has been discussed as a side effect in trials in both, FLT3 wild type and mutated acute myeloid leukemia (AML), as monotherapy or as combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Senapati, Jayastu, Devasia, Anup J., Ganapule, Abhijeet, George, Leni, Viswabandya, Auro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965723/
https://www.ncbi.nlm.nih.gov/pubmed/24678393
http://dx.doi.org/10.4084/MJHID.2014.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965723/
https://www.ncbi.nlm.nih.gov/pubmed/24678393
http://dx.doi.org/10.4084/MJHID.2014.016

Ejemplares similares